A highly successful example is the development of small molecule therapies using a simple cell-based in vitro assay for CFTR deficiency to develop therapeutics for cystic fibrosis (Langron et al., 2017; Phuan et al., 2018; Bacalhau et al., 2023). The gene discussed is CFTR; the disease is cystic fibrosis.